Cargando…
Diagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies
In the past years, what has always been considered undisputed true in liver fibrosis staging has been challenged. Diagnostic performance of histological evaluation has proven to be significantly influenced by sample- and observer-related variabilities. Differentiation between lower levels of fibrosi...
Autores principales: | Mendes, Leandro César, Stucchi, Raquel SB, Vigani, Aline G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892613/ https://www.ncbi.nlm.nih.gov/pubmed/29662329 http://dx.doi.org/10.2147/HMER.S125234 |
Ejemplares similares
-
Transient elastography and APRI score: looking at false positives and false negatives. Diagnostic performance and association to fibrosis staging in chronic hepatitis C
por: Mendes, L.C., et al.
Publicado: (2016) -
All-oral direct antiviral treatment for hepatitis C chronic infection in a real-life cohort: The role of cirrhosis and comorbidities in treatment response
por: Miotto, Noelle, et al.
Publicado: (2018) -
Cystic Fibrosis: Overview of the Current Development Trends and Innovative Therapeutic Strategies
por: Almughem, Fahad A., et al.
Publicado: (2020) -
Staging Fibrosis in Chronic Viral Hepatitis
por: Cardoso, Ana Carolina, et al.
Publicado: (2022) -
Treatment of hepatitis C virus genotype 3 infection with direct-acting antiviral agents
por: Zanaga, L.P., et al.
Publicado: (2016)